● Recruiting

AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

Condition: Mesial Temporal Lobe Epilepsy · Sponsor: UniQure Biopharma B.V.

PhasePhase 1/Phase 2

Planned participants12

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

The main goals of this clinical study are to learn if AMT-260 is safe and tolerable and works to reduce the frequency of seizures in adults with unilateral mesial temporal lobe epilepsy (MTLE).

This description comes directly from the study's public registry record.

Talk to the study team

uniQure · 1-866-520-1257 · medinfo@uniqure.com

Always discuss trial participation with your own doctor first.

Locations (18)

University of Alabama at Birmingham	Birmingham, Alabama, United States	Recruiting
Mayo Clinic Arizona	Phoenix, Arizona, United States	Recruiting
Stanford University	Palo Alto, California, United States	Recruiting
Mayo Clinic Florida	Jacksonville, Florida, United States	Recruiting
Kansas University Medical Center	Kansas City, Kansas, United States	Recruiting
Johns Hopkins School of Medicine	Baltimore, Maryland, United States	Recruiting
Midatlantic Epilepsy and Sleep Center	Bethesda, Maryland, United States	Recruiting
Massachusetts General Hospital	Boston, Massachusetts, United States	Recruiting
Corewell Health	Grand Rapids, Michigan, United States	Recruiting
Dartmouth Hitchcock Medical Center	Lebanon, New Hampshire, United States	Recruiting
Northeast Regional Epilepsy Group	Hackensack, New Jersey, United States	Recruiting
Robert Wood Johnson Hospital	New Brunswick, New Jersey, United States	Recruiting

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06063850